Kanada - Kifaransa - Health Canada

paula's choice llc - oxybenzone; dioxyde de titane; octinoxate; octisalate; oxyde de zinc - crème - 5.0%; 3.0%; 7.5%; 5.0%; 2.0% - oxybenzone 5.0%; dioxyde de titane 3.0%; octinoxate 7.5%; octisalate 5.0%; oxyde de zinc 2.0% - sunscreen agents

Kanada - Kifaransa - Health Canada

paula's choice llc - octisalate; octinoxate; octocrilène; avobenzone - lotion - 5%; 7.5%; 2%; 2% - octisalate 5%; octinoxate 7.5%; octocrilène 2%; avobenzone 2%

Kanada - Kifaransa - Health Canada

dolisos canada inc. - guarana - globules - 1x - guarana 1x - homeopathic products

Kanada - Kifaransa - Health Canada

sensible life products - thymol - pulvérisation - 0.23% - thymol 0.23% - disinfectants (for agents used on object)

Kanada - Kifaransa - Health Canada

sensible life products - thymol - pulvérisation - 0.23% - thymol 0.23% - disinfectants (for agents used on object)

Umoja wa Ulaya - Kifaransa - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Kanada - Kifaransa - Health Canada

den-mat holdings, llc - doxycycline (hyclate de doxycycline) - gel (à libération prolongée) - 8.8% - doxycycline (hyclate de doxycycline) 8.8% - antibacterials

Kanada - Kifaransa - Health Canada

cubist pharmaceuticals llc - daptomycine - poudre pour solution - 500mg - daptomycine 500mg - cyclic lipopeptides

Kanada - Kifaransa - Health Canada

cubist pharmaceuticals llc - daptomycine - poudre pour solution - 500mg - daptomycine 500mg - cyclic lipopeptides

Kanada - Kifaransa - Health Canada

lundbeck pharmaceuticals llc - vigabatrine - comprimé - 500mg - vigabatrine 500mg - miscellaneous anticonvulsants